Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Diabetes Research and Clinical Practice|April 4, 2024
Prevalence of gestational diabetes mellitus risk factors in singleton pregnancies obtained by assisted reproductive technology: An observational, retrospective, real-world study from a pregnancy registryMichela Vergani, Matteo Conti, Alessia Lari, et al.The Journal of Clinical Endocrinology and Metabolism|February 25, 2015
Serum thyroid hormone autoantibodies in type 1 diabetes mellitusSalvatore Benvenga, Basilio Pintaudi, Roberto Vita, et al.International Journal of Endocrinology|June 27, 2020
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological ManagementArianna Pani, Ilaria Gironi, Giacoma Di Vieste, et al.Frontiers in Endocrinology|March 13, 2025
Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOSPaola Quaresima, Samuel H Myers, Basilio Pintaudi, et al.Frontiers in Endocrinology|February 17, 2025
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOSPaola Quaresima, Samuel H Myers, Basilio Pintaudi, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 22, 2022
Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitusBasilio Pintaudi, Ilaria Gironi, Riccardo Nicosia, et al.Diabetes, Obesity & Metabolism|October 7, 2022
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of eventsEdoardo Mannucci, Marco Gallo, Andrea Giaccari, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 23, 2021
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trialsEdoardo Mannucci, Lara Naletto, Gabriele Vaccaro, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 11, 2022
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trialsEdoardo Mannucci, Andrea Giaccari, Marco Gallo, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 11, 2021
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trialsEdoardo Mannucci, Marco Gallo, Basilio Pintaudi, et al.Pageof 7